P

Inventor

FOSTER DON

US14 patents
⚠️ This page may combine multiple inventors who share the name “FOSTER DON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALNYLAM PHARMACEUTICALS INC

10 patents
US10612027B2Apr 7, 2020

Modified double-stranded RNA agents

ALNYLAM PHARMACEUTICALS INC26 citations97
US10233448B2Mar 19, 2019

Modified double-stranded RNA agents

ALNYLAM PHARMACEUTICALS INC37 citations97
US10612024B2Apr 7, 2020

Modified double-stranded RNA agents

ALNYLAM PHARMACEUTICALS INC15 citations93
US11401517B2Aug 2, 2022

Modified double-stranded RNA agents

ALNYLAM PHARMACEUTICALS INC6 citations85
US12385044B2Aug 12, 2025

Modified double-stranded RNA agents

ALNYLAM PHARMACEUTICALS INC0 citations62
US12385043B2Aug 12, 2025

Modified double-stranded RNA agents

ALNYLAM PHARMACEUTICALS INC0 citations62
US12378553B2Aug 5, 2025

Modified double-stranded RNA agents

ALNYLAM PHARMACEUTICALS INC0 citations62
US12168767B2Dec 17, 2024

Modified double-stranded RNA agents

ALNYLAM PHARMACEUTICALS INC0 citations62
US11549109B2Jan 10, 2023

Modified double-stranded RNA agents

ALNYLAM PHARMACEUTICALS INC0 citations62
US11427822B2Aug 30, 2022

Modified double-stranded RNA agents

ALNYLAM PHARMACEUTICALS INC0 citations62

NOVO NORDISK AS

2 patents
US6268163B1Jul 31, 2001

Identification of drug candidates modulating factor VII-mediated intracellular signaling

NOVO NORDISK AS19 citations90
US6461610B1Oct 8, 2002

Methods for modifying cell motility using factor VIIa or inactivated factor VIIa

NOVO NORDISK AS27 citations88

BETTENCOURT BRIAN

1 patent
US9228188B2Jan 5, 2016

Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression

BETTENCOURT BRIAN8 citations82

(unassigned)

1 patent
US5616324AApr 1, 1997

Pro-inflammatory composition comprising at least two members of the group consisting of DL. phenylalanine, ruta graveolans and corydalis bulbosda

15 citations64